Health Care/Hospital

Docquity's AI Platform Enhances Medical Knowledge and Patient Care at RSUD Umar Wirahadikusumah Sumedang

* Dx, Docquity's AI platform which is in ongoing development, will enable physicians at the Sumedanghospital to securely access the latest medical research for stronger treatment decisions * The collaboration follows Sumedang Regency's introduction of Docquity's AI platform for greater public...

2025-03-06 10:00 5242

Suvoda launches Sofia, a new AI assistant to simplify management of clinical trials

From many clicks to one query, drug supply managers can more quickly access, analyze, and visualize the trial supply data they need. PHILADELPHIA, March 6, 2025 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like on...

2025-03-05 23:17 2428

Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative cancer therapy based on membrane lipid therapy, announced today optimistic results from its ongoing clinical trial evaluating LAM561 for the treatment of newly diagnosed glioblastoma ...

2025-03-05 22:45 2202

Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

ROCKVILLE, Md., March 5, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend) , a gene to GMP advanced therapy development partner, today announced the appointment ofJohn Chiminski and Karen Flynn as non-executive members of its Board of Directors. John will ser...

2025-03-05 22:33 2953

EMFACE Surpasses 1 Million Treatments, Becoming the Fastest-Growing Non-Invasive Facial Lifting Procedure

PRAGUE, March 5, 2025 /PRNewswire/ -- EMFACE, the revolutionary non-invasive facial treatment, has reached an extraordinary milestone—becoming the fastest procedure of its kind to surpass 1 million treatments worldwide in just under two years. This achievement cements EMFACE as the leading non-in...

2025-03-05 22:00 2189

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to$30.6 million in 2024 Cash and short-term assets of $84.8 million as of December 31, 2024 Provides first quarter and full year 2025 guidance Projects full year 2025 revenue of $73 million to $85 million, driven ...

2025-03-05 21:32 4921

The Laughing Cow - Southeast Asia Region Wins Prestigious Brand of Asia 2024-25 Award

SINGAPORE, March 5, 2025 /PRNewswire/ -- The Laughing Cow  has been honored with the Prestigious Brands ofAsia 2024-25 award in the FMCG - Cheese category. This recognition, presented at the Global Business Symposium hosted by H...

2025-03-05 19:56 3250

CQ Medical's Iris AirShuttle™ Patient Transfer Platform Recognized at Women in Innovation Award Showcase

AVONDALE, Pa., March 5, 2025 /PRNewswire/ -- The Iris AirShuttle™, a patient transfer platform developed by CQ Medical, is designed to streamline the transfer of patients from procedures to imaging. Recently, it was featured at theWomen in Innovation Award Showcase, an event that celebrated Profe...

2025-03-05 18:00 1847

BTL's EMFACE Surpasses 1 Million Treatments, Becoming the Fastest-Growing Non-Invasive Facial Lifting Procedure

PRAGUE, March 5, 2025 /PRNewswire/ -- EMFACE, the revolutionary non-invasive facial treatment, has reached an extraordinary milestone—becoming the fastest procedure of its kind to surpass 1 million treatments worldwide in just under two years. This achievement cements EMFACE as the leading non-in...

2025-03-05 17:00 3184

Business Plan Contest "Photonics Challenge 2025" was Successfully Held in Hamamatsu City, the Center of the Optical Industry

Three companies with outstanding optical technology –  Beyond Optical Medical Technologies, Ectobrain Devices and Catana Corporation – presented groundbreaking ideas and are awarded for their business plans HAMAMATSU, Japan, March 5, 2025 /PRNewswire/ -- The Central Japan Startup Ecosystem Consor...

2025-03-05 13:43 3119

CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland

* CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide manufacturing facilities acrossEurope and the US. * In Switzerland, CordenPharma will invest >€500m to construct a greenfield site for small to lar...

2025-03-05 13:30 2777

XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene's Commercial Presence in APAC

- XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia. - From the second half of 2024 to now, XPOVIO® was successively approved in Thailand, Malaysia and Indonesia, significantly expanding Antengene's commercial presence in APAC. To date, XPOVIO® has been approved for multiple ind...

2025-03-05 13:00 2709

InterSystems Unveils IntelliCare: A Next-Generation, AI-Powered Electronic Health Record

BANGKOK, March 5, 2025 /PRNewswire/ -- InterSystems , a creative data technology provider managing over one billion health records globally, today announced the launch of InterSystems IntelliCare , an AI-powered el...

2025-03-05 12:43 2454

Pantai Hospital Kuala Lumpur and IMU University Sign MoU to Advance Medical Research and Education

KUALA LUMPUR, Malaysia, March 5, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) and IMU University have officially entered into a five-year Memorandum of Understanding (MoU) to foster collaboration in biomedical science research, training, and knowledge exchange. This partnership marks ...

2025-03-05 12:35 2569

GHIT-backed Innovation Achieves Landmark: New Treatment Option for Schistosomiasis Reaches Preschool-Aged Children

TOKYO, March 5, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund is today announcing a significant milestone: the first administration of arpraziquantel to preschool-aged children inUganda, in an implementation science setting. This new pediatric treatment for schistosomi...

2025-03-05 09:00 2462

The Chinese carbon ion center Heyou Hospital selects RayStation

STOCKHOLM, March 4, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that Heyou Hospital, located in Foshan City,Guangdong Province, China, has placed an order for the treatment planning system RayStation®*. Total order value (including service contract) is RMB 51 mill...

2025-03-04 18:48 2090

Ping An Enhances Recruitment Experience with "Ping An Talent" AI System

HONG KONG and SHANGHAI, March 4, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", "the Company" or the "Group" HKEX: 2318 / 82318; SSE: 601318) recently launched its 2025 Spring Campus Recruitment offering over 2,000 positions, highlighted byPing An's sel...

2025-03-04 18:09 3369

Chulalongkorn University Unveils Exoskeleton Wheelchair to Aid Mobility

BANGKOK, March 4, 2025 /PRNewswire/ -- Chulalongkorn University  has introduced the Exoskeleton Wheelchair , an innovative robotic suit designed to help people with disabilities stand, walk, and move more independently. T...

2025-03-04 12:16 3967

Raziel and Fosun Pharma (by JuveStar an affiliate company of Fosun Pharma) Initiate Phase 3 Registration Trial in China for Submental Fat Reduction ("double chin")

REROVOT, Israel, March 4, 2025 /PRNewswire/ -- Raziel Therapeutics, a pharmaceutical company developing next-generation novel prescription products for the medical aesthetics market, announces phase 3 study initiation inChina for the treatment of fat reduction in the submental area. Submental fat...

2025-03-04 09:00 2144

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

MELBOURNE, Australia and INDIANAPOLIS, Ind., March 4, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) invites investors to join a webinar showcasing the Company's late-stage and next-generation radiotherapeutic candidates in urologic oncology. In ...

2025-03-04 05:58 2527
1 ... 130131132133134135136 ... 540